New antithrombotic drugs and European approval processes.
作者信息
Marijon Eloi, Fauchier Laurent, Le Heuzey Jean-Yves
出版信息
Lancet. 2011 Aug 20;378(9792):662-3. doi: 10.1016/S0140-6736(11)61327-5.
Abstract
摘要
相似文献
1
New antithrombotic drugs and European approval processes.新型抗血栓药物与欧洲审批流程
Lancet. 2011 Aug 20;378(9792):662-3. doi: 10.1016/S0140-6736(11)61327-5.
2
[New oral anticoagulants are as safe in elderly patients as conventional drugs].新型口服抗凝药在老年患者中与传统药物一样安全。
Praxis (Bern 1994). 2014 Aug 20;103(17):1032. doi: 10.1024/1661-8157/a001749.
3
[New oral anticoagulant agents: the quandary of anticoagulation in the elderly].[新型口服抗凝剂：老年人抗凝治疗的困境]
Med Clin (Barc). 2013 Oct 19;141(8):346-8. doi: 10.1016/j.medcli.2013.05.011. Epub 2013 Jul 5.
4
[Differential therapy with the new anticoagulants, 5].[新型抗凝剂的差异疗法，5]
MMW Fortschr Med. 2013 May 16;155(9):20. doi: 10.1007/s15006-013-0676-8.
5
New antithrombotic drugs for atrial fibrillation: caution is needed.用于心房颤动的新型抗血栓药物：需谨慎使用。
Lancet. 2012 Jan 28;379(9813):e24; author reply e24-5. doi: 10.1016/S0140-6736(12)60146-9.
6
[Atrial fibrillation: what the GP needs to know].[心房颤动：全科医生需要了解的内容]
MMW Fortschr Med. 2011 Sep 22;153(38):44-7; quiz 48.
7
New antithrombotic drugs: a revolution in stroke management.新型抗血栓药物：中风治疗的一场革命。
Cardiovasc J Afr. 2012 Mar;23(2):61-2.
8
[Clinical management of the new anticoagulants].[新型抗凝剂的临床管理]
Neurologia. 2012 Mar;27 Suppl 1:33-8. doi: 10.1016/S0213-4853(12)70006-3.
9
[Your patient needs antithrombotics, 2. What do the new substances offer? (interview by Dr. med. Peter Stiefelhagen)].[您的患者需要抗血栓药物，2. 这些新物质有什么作用？（医学博士彼得·施蒂费尔哈根访谈）]
MMW Fortschr Med. 2013 Feb 21;155(3):18. doi: 10.1007/s15006-013-0149-0.
10
[New oral anticoagulants in venous thromboembolism. General practice information on switching, monitoring, pausing].[新型口服抗凝药用于静脉血栓栓塞症。关于转换、监测、暂停用药的全科医学信息]
MMW Fortschr Med. 2015 Jan 19;157(1):24. doi: 10.1007/s15006-015-2575-7.
Zotero 插件